Beijing Sungen Biomedical Technology Co.
- Biotech or pharma, therapeutic R&D
Beijing Sungen Biomedical Technology Co., Ltd is an innovation-driven, clinical-stage biotechnology company founded in 2018, dedicated to advancing human health through cutting-edge technologies. We are pioneering the development of First-in-Class (FIC) and Best-in-Class (BIC) antibody-based therapeutics, including monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), ADCs and Antibody-oligonucleotide conjugates (AOCs). Supported by a team of dedicated researchers and management with successful biotechnology entrepreneur experiences, Sungen has developed international level major research and manufacturing platforms in-house, such as AI-powered drug discovery platform, animal resource center, and CMC workshops. We leverage our innovative technology platforms to transform targeted therapies, focusing on cardiovascular, tumor, and neurodegenerative diseases.
It is our commitment to address critical unmet clinical needs and improve patient outcomes worldwide.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}